These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36084067)

  • 1. Multiple criteria decision analysis for therapeutic innovations in a hemophilia care center: A pilot study of the organizational impact of innovation in hemophilia care management.
    Beny K; Dubromel A; du Sartz de Vigneulles B; Gay V; Carrouel F; Negrier C; Dussart C
    PLoS One; 2022; 17(9):e0273775. PubMed ID: 36084067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple criteria decision analysis approach to consider therapeutic innovations in the emergency department: The methoxyflurane organizational impact in acute trauma pain.
    Lvovschi VE; Maignan M; Tazarourte K; Diallo ML; Hadjadj-Baillot C; Pons-Kerjean N; Lapostolle F; Dussart C
    PLoS One; 2020; 15(4):e0231571. PubMed ID: 32294125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' Perception of the Impact of Innovation on Hemophilia Care Management Organization: A Qualitative Study Protocol (INNOVHEMO Study).
    Beny K; du Sartz de Vigneulles B; Chamouard V; Guilloux R; Gay V; Negrier C; Dussart C
    Patient Prefer Adherence; 2021; 15():1807-1815. PubMed ID: 34434044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
    Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
    BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
    Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
    Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative.
    Tarantino MD; Pindolia VK
    J Manag Care Spec Pharm; 2017 Jan; 23(1):51-56. PubMed ID: 28025929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of Innovative Ideas Recorded by Nurses in an Ideas Bank of a Corporate Virtual Community of Open Innovation: A Cross-Sectional Study.
    Planas-Campmany C; Zabaleta-Del-Olmo E; Violán C; Pérez-Sánchez G; Navas-Palacios JJ
    J Nurs Scholarsh; 2020 Jul; 52(4):426-434. PubMed ID: 32346930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
    Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
    BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of an online decision support tool for organizational readiness for change.
    Khan S; Timmings C; Moore JE; Marquez C; Pyka K; Gheihman G; Straus SE
    Implement Sci; 2014 May; 9():56. PubMed ID: 24886072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making sense of evidence in management decisions: the role of research-based knowledge on innovation adoption and implementation in healthcare. study protocol.
    Kyratsis Y; Ahmad R; Holmes A
    Implement Sci; 2012 Mar; 7():22. PubMed ID: 22436094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-criteria decision analysis in clinical comprehensive evaluation of Chinese patent medicine].
    Dai ZQ; Xu SM; Wu X; Li MM; Hu J; Liao X
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3155-3160. PubMed ID: 35851106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to treatment among persons with hemophilia: A spatial analysis assessment in the Rhone-Alpes region, France.
    Leroy V; Freyssenge J; Renard F; Tazarourte K; Négrier C; Chamouard V
    J Am Pharm Assoc (2003); 2019; 59(6):797-803. PubMed ID: 31405805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typology of organizational innovation components: building blocks to improve access to primary healthcare for vulnerable populations.
    Smithman MA; Descôteaux S; Dionne É; Richard L; Breton M; Khanassov V; Haggerty JL;
    Int J Equity Health; 2020 Oct; 19(1):174. PubMed ID: 33023575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritising health service innovation investments using public preferences: a discrete choice experiment.
    Erdem S; Thompson C
    BMC Health Serv Res; 2014 Aug; 14():360. PubMed ID: 25167926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.
    Kremer IEH; Jongen PJ; Evers SMAA; Hoogervorst ELJ; Verhagen WIM; Hiligsmann M
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):123. PubMed ID: 33836742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 - an opportunity to improve access to primary care through organizational innovations? A qualitative multiple case study in Quebec and Nova Scotia (Canada).
    Breton M; Marshall EG; Deslauriers V; Smithman MA; Moritz LR; Buote R; Morrison B; Christian EK; McKay M; Stringer K; Godard-Sebillotte C; Sourial N; Laberge M; MacKenzie A; Isenor JE; Duhoux A; Ashcroft R; Mathews M; Cossette B; Hudon C; McDougall B; Guénette L; Kirkwood R; Green ME
    BMC Health Serv Res; 2022 Jun; 22(1):759. PubMed ID: 35676668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Multicriteria Decision Analysis to Determine the Value of Prophylaxis Relative to On-Demand Treatment in Hemophilia A and Emicizumab versus Replacement Therapy in the Greek Healthcare Setting.
    Gourzoulidis G; Stefanou G; Economou M; Vakalopoulou S; Filippidis G; Soultatis G; Kontos D; Tzima S; Ntemousis F; Fassa A; Kourlaba G
    Clin Drug Investig; 2022 Jan; 42(1):75-85. PubMed ID: 34874542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.